Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma.
Mukherjee N, Amato CM, Skees J, Todd KJ, Lambert KA, Robinson WA, Van Gulick R, Weight RM, Dart CR, Tobin RP, McCarter MD, Fujita M, Norris DA, Shellman YG.
Mukherjee N, et al. Among authors: robinson wa.
Cancers (Basel). 2020 Aug 5;12(8):2182. doi: 10.3390/cancers12082182.
Cancers (Basel). 2020.
PMID: 32764384
Free PMC article.